Advanced Oncotherapy ups final tranche of fundraise

Advanced Oncotherapy CEO Nicolas Serandour

Advanced Oncotherapy said today that high levels of investor demand had caused it to increase the size of its open offer by 16%. It now…

You must be a HM Subscriber to view this content.

Subscribe Now »